Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794083991> ?p ?o ?g. }
- W2794083991 endingPage "e1002528" @default.
- W2794083991 startingPage "e1002528" @default.
- W2794083991 abstract "Atrial fibrillation (AF) is associated with substantial morbidity, in particular stroke. Despite good evidence for the reduction of stroke risk with anticoagulant therapy, there remains significant undertreatment. The main aim of the current study was to investigate whether a clinical decision support tool (CDS) for stroke prevention integrated in the electronic health record could improve adherence to guidelines for stroke prevention in patients with AF.We conducted a cluster-randomized trial where all 43 primary care clinics in the county of Östergötland, Sweden (population 444,347), were randomized to be part of the CDS intervention or to serve as controls. The CDS produced an alert for physicians responsible for patients with AF and at increased risk for thromboembolism (according to the CHA2DS2-VASc algorithm) without anticoagulant therapy. The primary endpoint was adherence to guidelines after 1 year. After randomization, there were 22 and 21 primary care clinics in the CDS and control groups, respectively. There were no significant differences in baseline adherence to guidelines regarding anticoagulant therapy between the 2 groups (CDS group 70.3% [5,186/7,370; 95% CI 62.9%-77.7%], control group 70.0% [4,187/6,009; 95% CI 60.4%-79.6%], p = 0.83). After 12 months, analysis with linear regression with adjustment for primary care clinic size and adherence to guidelines at baseline revealed a significant increase in guideline adherence in the CDS (73.0%, 95% CI 64.6%-81.4%) versus the control group (71.2%, 95% CI 60.8%-81.6%, p = 0.013, with a treatment effect estimate of 0.016 [95% CI 0.003-0.028]; number of patients with AF included in the final analysis 8,292 and 6,508 in the CDS and control group, respectively). Over the study period, there was no difference in the incidence of stroke, transient ischemic attack, or systemic thromboembolism in the CDS group versus the control group (49 [95% CI 43-55] per 1,000 patients with AF in the CDS group compared to 47 [95% CI 39-55] per 1,000 patients with AF in the control group, p = 0.64). Regarding safety, the CDS group had a lower incidence of significant bleeding, with events in 12 (95% CI 9-15) per 1,000 patients with AF compared to 16 (95% CI 12-20) per 1,000 patients with AF in the control group (p = 0.04). Limitations of the study design include that the analysis was carried out in a catchment area with a high baseline adherence rate, and issues regarding reproducibility to other regions.The present study demonstrates that a CDS can increase guideline adherence for anticoagulant therapy in patients with AF. Even though the observed difference was small, this is the first randomized study to our knowledge indicating beneficial effects with a CDS in patients with AF.ClinicalTrials.gov NCT02635685." @default.
- W2794083991 created "2018-03-29" @default.
- W2794083991 creator A5018015038 @default.
- W2794083991 creator A5021288139 @default.
- W2794083991 creator A5023142366 @default.
- W2794083991 creator A5046892023 @default.
- W2794083991 creator A5058539268 @default.
- W2794083991 creator A5069913131 @default.
- W2794083991 date "2018-03-13" @default.
- W2794083991 modified "2023-10-16" @default.
- W2794083991 title "A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study)" @default.
- W2794083991 cites W189395037 @default.
- W2794083991 cites W1922843089 @default.
- W2794083991 cites W1980771486 @default.
- W2794083991 cites W1999468381 @default.
- W2794083991 cites W2004592440 @default.
- W2794083991 cites W2009734530 @default.
- W2794083991 cites W2011936209 @default.
- W2794083991 cites W2023143117 @default.
- W2794083991 cites W2023603983 @default.
- W2794083991 cites W2030434108 @default.
- W2794083991 cites W2030466875 @default.
- W2794083991 cites W2059459859 @default.
- W2794083991 cites W2062780855 @default.
- W2794083991 cites W2073924861 @default.
- W2794083991 cites W2083062358 @default.
- W2794083991 cites W2098240323 @default.
- W2794083991 cites W2101692118 @default.
- W2794083991 cites W2104343448 @default.
- W2794083991 cites W2110922423 @default.
- W2794083991 cites W2115441252 @default.
- W2794083991 cites W2127765788 @default.
- W2794083991 cites W2130163055 @default.
- W2794083991 cites W2130796303 @default.
- W2794083991 cites W2141347595 @default.
- W2794083991 cites W2141403362 @default.
- W2794083991 cites W2143428311 @default.
- W2794083991 cites W2147018083 @default.
- W2794083991 cites W2159072650 @default.
- W2794083991 cites W2162586165 @default.
- W2794083991 cites W2167423131 @default.
- W2794083991 cites W2344977044 @default.
- W2794083991 cites W2403627085 @default.
- W2794083991 cites W2472261290 @default.
- W2794083991 cites W2582258891 @default.
- W2794083991 cites W2587959611 @default.
- W2794083991 cites W2588800208 @default.
- W2794083991 cites W2594848887 @default.
- W2794083991 cites W2603057432 @default.
- W2794083991 cites W2750530717 @default.
- W2794083991 cites W4234180827 @default.
- W2794083991 doi "https://doi.org/10.1371/journal.pmed.1002528" @default.
- W2794083991 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5849292" @default.
- W2794083991 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29534063" @default.
- W2794083991 hasPublicationYear "2018" @default.
- W2794083991 type Work @default.
- W2794083991 sameAs 2794083991 @default.
- W2794083991 citedByCount "70" @default.
- W2794083991 countsByYear W27940839912018 @default.
- W2794083991 countsByYear W27940839912019 @default.
- W2794083991 countsByYear W27940839912020 @default.
- W2794083991 countsByYear W27940839912021 @default.
- W2794083991 countsByYear W27940839912022 @default.
- W2794083991 countsByYear W27940839912023 @default.
- W2794083991 crossrefType "journal-article" @default.
- W2794083991 hasAuthorship W2794083991A5018015038 @default.
- W2794083991 hasAuthorship W2794083991A5021288139 @default.
- W2794083991 hasAuthorship W2794083991A5023142366 @default.
- W2794083991 hasAuthorship W2794083991A5046892023 @default.
- W2794083991 hasAuthorship W2794083991A5058539268 @default.
- W2794083991 hasAuthorship W2794083991A5069913131 @default.
- W2794083991 hasBestOaLocation W27940839911 @default.
- W2794083991 hasConcept C126322002 @default.
- W2794083991 hasConcept C127413603 @default.
- W2794083991 hasConcept C142724271 @default.
- W2794083991 hasConcept C168563851 @default.
- W2794083991 hasConcept C176400912 @default.
- W2794083991 hasConcept C1862650 @default.
- W2794083991 hasConcept C194828623 @default.
- W2794083991 hasConcept C203092338 @default.
- W2794083991 hasConcept C204243189 @default.
- W2794083991 hasConcept C2778205648 @default.
- W2794083991 hasConcept C2779161974 @default.
- W2794083991 hasConcept C2780182762 @default.
- W2794083991 hasConcept C2780645631 @default.
- W2794083991 hasConcept C2908647359 @default.
- W2794083991 hasConcept C535046627 @default.
- W2794083991 hasConcept C71924100 @default.
- W2794083991 hasConcept C78519656 @default.
- W2794083991 hasConcept C99454951 @default.
- W2794083991 hasConceptScore W2794083991C126322002 @default.
- W2794083991 hasConceptScore W2794083991C127413603 @default.
- W2794083991 hasConceptScore W2794083991C142724271 @default.
- W2794083991 hasConceptScore W2794083991C168563851 @default.
- W2794083991 hasConceptScore W2794083991C176400912 @default.
- W2794083991 hasConceptScore W2794083991C1862650 @default.
- W2794083991 hasConceptScore W2794083991C194828623 @default.
- W2794083991 hasConceptScore W2794083991C203092338 @default.